Banco Bilbao Vizcaya Argentaria, S.A. Trevena Inc Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 12, 2020	SELL	$1.53 - $3.13 $688,500 - $1.41 Million	-450,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.62 - $1.06 $279,000 - $477,000	450,000 New	450,000 $378,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.